

Fundamental dimension Equity attribute | CPSPeer $20.39▲+0.15% Cap $362.3MP/E -6.5x QuantScore40/100 | AXLPeer $8.62▲+4.99% Cap $1.02BP/E -6.2x QuantScore40/100 | CARSLeader $10.94▲+0.27% Cap $611.6MP/E 18.7x QuantScore60/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
46/100 |
74/100 |
83/100 |
Valuation Multiples, PEG & DCF upside | 50/100 | 67/100 | 97/100 |
Health Piotroski, Altman Z, leverage & liquidity | 27/100 | 30/100 | 48/100 |
Growth Revenue / earnings growth & margins | 26/100 | 1/100 | 25/100 |
Sentiment Analyst ratings, targets & revisions | 50/100 | 28/100 | 45/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -6.5x | -6.2x | 18.7x |
Forward P/E (next FY) | 14.1x | 18.3x | 5.5x |
EV / EBITDA (TTM) | 7300.8x | 0.6x | 7.2x |
Price / Sales | 0.1x | 0.1x | 0.8x |
Price / Free Cash Flow | -74.0x | -41.1x | 4.1x |
PEG ratio | 0.15 | -0.12 | -2.36 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 3 / 9 | 9 / 9 |
Altman Z-Score | -0.24 (Distress) | 0.92 (Distress) | 0.43 (Distress) |
Total debt / equity | -9.15 | 0.11 | 1.01 |
Quick ratio | 1.1x | 1.0x | 2.0x |
Interest coverage | 0.8x | -0.4x | 5.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +0.4% | -4.7% | +0.6% |
Net income growth YoY | +94.7% | -156.3% | -58.4% |
Gross margin (TTM) | 11.3% | 10.9% | 83.0% |
Operating margin (FY) | 3.9% | 1.9% | 8.3% |
FCF margin (FY) | 0.6% | 2.7% | 20.4% |
5. Trailing price performancePrice change over period |
1M return | -8.2% | 0.0% | +3.1% |
3M return | -28.2% | +40.6% | -4.5% |
6M return | -36.7% | +41.5% | -1.9% |
Year to date | -37.9% | +32.8% | -10.3% |
1Y return | -47.1% | +87.8% | -3.2% |
3Y return | +75.3% | -5.6% | -32.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $213.15 +945.4% upside | $72.43 +740.2% upside | $30.65 +180.2% upside |
Wall Street consensus target | $32.00 +56.9% · range $32.00–$32.00 | $9.79 +13.6% · range $7.00–$17.00 | $11.50 +5.1% · range $11.50–$11.50 |
Consensus stance | 20% Buy50% Hold30% Sell | 35% Buy45% Hold20% Sell | 63% Buy38% Hold0% Sell |